| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |